Hepatitis C in liver transplant patients

Scott Fink, Paul J. Gaglio

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) presents multiple challenges related to liver transplantation; it is the most common indication for liver transplantation in the United States but is universally recurrent in patients who are viremic at the time of transplantation. When HCV recurs in the transplanted liver, histologic injury may be severe, and progression toward advanced fibrosis with decompensation is more rapid when compared with the natural history of HCV before transplantation. This review summarizes new information related to the treatment, recognition, and management of HCV in patients who undergo liver transplantation.

Original languageEnglish (US)
Pages (from-to)81-87
Number of pages7
JournalCurrent Hepatitis Reports
Volume7
Issue number2
DOIs
StatePublished - Jun 2008

Fingerprint

Hepatitis C
Hepacivirus
Liver Transplantation
Transplants
Liver
Transplantation
Natural History
Fibrosis
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Hepatology
  • Virology

Cite this

Hepatitis C in liver transplant patients. / Fink, Scott; Gaglio, Paul J.

In: Current Hepatitis Reports, Vol. 7, No. 2, 06.2008, p. 81-87.

Research output: Contribution to journalArticle

Fink, Scott ; Gaglio, Paul J. / Hepatitis C in liver transplant patients. In: Current Hepatitis Reports. 2008 ; Vol. 7, No. 2. pp. 81-87.
@article{aac8222e9afe44e581ac837dab2e8c48,
title = "Hepatitis C in liver transplant patients",
abstract = "Hepatitis C virus (HCV) presents multiple challenges related to liver transplantation; it is the most common indication for liver transplantation in the United States but is universally recurrent in patients who are viremic at the time of transplantation. When HCV recurs in the transplanted liver, histologic injury may be severe, and progression toward advanced fibrosis with decompensation is more rapid when compared with the natural history of HCV before transplantation. This review summarizes new information related to the treatment, recognition, and management of HCV in patients who undergo liver transplantation.",
author = "Scott Fink and Gaglio, {Paul J.}",
year = "2008",
month = "6",
doi = "10.1007/s11901-008-0012-4",
language = "English (US)",
volume = "7",
pages = "81--87",
journal = "Current Hepatitis Reports",
issn = "1540-3416",
publisher = "Springer Publishing Company",
number = "2",

}

TY - JOUR

T1 - Hepatitis C in liver transplant patients

AU - Fink, Scott

AU - Gaglio, Paul J.

PY - 2008/6

Y1 - 2008/6

N2 - Hepatitis C virus (HCV) presents multiple challenges related to liver transplantation; it is the most common indication for liver transplantation in the United States but is universally recurrent in patients who are viremic at the time of transplantation. When HCV recurs in the transplanted liver, histologic injury may be severe, and progression toward advanced fibrosis with decompensation is more rapid when compared with the natural history of HCV before transplantation. This review summarizes new information related to the treatment, recognition, and management of HCV in patients who undergo liver transplantation.

AB - Hepatitis C virus (HCV) presents multiple challenges related to liver transplantation; it is the most common indication for liver transplantation in the United States but is universally recurrent in patients who are viremic at the time of transplantation. When HCV recurs in the transplanted liver, histologic injury may be severe, and progression toward advanced fibrosis with decompensation is more rapid when compared with the natural history of HCV before transplantation. This review summarizes new information related to the treatment, recognition, and management of HCV in patients who undergo liver transplantation.

UR - http://www.scopus.com/inward/record.url?scp=51949095071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51949095071&partnerID=8YFLogxK

U2 - 10.1007/s11901-008-0012-4

DO - 10.1007/s11901-008-0012-4

M3 - Article

AN - SCOPUS:51949095071

VL - 7

SP - 81

EP - 87

JO - Current Hepatitis Reports

JF - Current Hepatitis Reports

SN - 1540-3416

IS - 2

ER -